Oxaliplatin-induced neuropathic pain in cancer: animal models and related research progress

Oxaliplatin-induced neuropathic pain in cancer: animal models and related research progress

Oxaliplatin, a third-generation platinum-based chemotherapeutic agent, has shown substantial efficacy in cancer treatment. However, its associated side effects, particularly chemotherapy-induced peripheral neuropathic pain (CIPNP), continue to challenge cancer survivors globally. Clinically, it freq...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuxin Jiang, Jie Shi, Wenping Wang, Haozhe Piao, Huini Yao, Jun Yu, Zhenzhu Zhai, Qian Liu, Ningxin Li, Jiaqing Fu, Yue Shen, Shengbo Jin, Mingzhu Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Pharmacology
Subjects:
oxaliplatin
neuropathic pain
CINP animal model
chemotherapy
applications
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1609791/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2025.1609791/full

Similar Items